David Dantzker - Feb 8, 2024 Form 4 Insider Report for SURMODICS INC (SRDX)

Role
Director
Signature
/s/ John Manders, on behalf of David R. Dantzker
Stock symbol
SRDX
Transactions as of
Feb 8, 2024
Transactions value $
$0
Form type
4
Date filed
2/12/2024, 04:16 PM
Previous filing
Jan 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRDX Common Stock Award $0 +1.8K +4.83% $0.00 39.1K Feb 8, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRDX Stock Option (right to buy) Award $0 +3.85K $0.00 3.85K Feb 8, 2024 Common Stock 3.85K $31.89 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The amount beneficially owned includes 15,772 restricted stock units (RSUs) that vest on service-based vesting dates and 15,415 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
F2 The stock options vest ratably on a monthly basis and become fully vested on February 8, 2025, the 12-month anniversary of the grant date.